Literature DB >> 2744065

Plasma cholinesterase activity in patients during therapy with dexamethasone or prednisone.

V Bradamante1, E Kunec-Vajić, M Lisić, I Dobrić, I Beus.   

Abstract

We have studied the effects of i.v. dexamethasone and oral prednisone on plasma cholinesterase (ChE) activity in 13 male and 10 female patients during long-term treatment with dexamethasone or prednisone. A decrease in ChE activity--probably due to inhibition of ChE synthesis in the liver--was seen in all the patients. In individual patients there was a drop in enzyme activity of 14-57% (dexamethasone) and 23-69% (prednisone) respectively, compared with individual control values. After withdrawal of dexamethasone, ChE activity in most cases increased to above control values and the period necessary for complete restoration of ChE activity was variable (between 25-70 days). Our results suggest that the decrease in ChE activity in patients treated with dexamethasone or prednisone depends on the initial dose of the drug as well as on the duration of treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744065     DOI: 10.1007/bf00558156

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

1.  Comparison of toxicity of intravenously given local anesthetic agents in man.

Authors:  F F FOLDES; R MOLLOY; P G McNALL; L R KOUKAL
Journal:  J Am Med Assoc       Date:  1960-04-02

2.  On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.

Authors:  W KALOW; N STARON
Journal:  Can J Biochem Physiol       Date:  1957-12

3.  Serum cholinesterase activity in the normal individual and in people with liver disease.

Authors:  K KAUFMAN
Journal:  Ann Intern Med       Date:  1954-09       Impact factor: 25.391

4.  Sensitivity to succinylcholine in relation to serum-cholinesterase.

Authors:  F T EVANS; P W S GRAY; H LEHMANN; E SILK
Journal:  Lancet       Date:  1952-06-21       Impact factor: 79.321

5.  The neuromuscular effects of suxamethonium in man.

Authors:  R L Katz; J F Ryan
Journal:  Br J Anaesth       Date:  1969-05       Impact factor: 9.166

6.  The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.

Authors:  F F Foldes; J C Smith
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

Review 7.  Biological function of cholinesterase.

Authors:  K M Kutty
Journal:  Clin Biochem       Date:  1980-12       Impact factor: 3.281

8.  Serum cholinesterase, pregnancy and suxamethonium.

Authors:  J A Wildsmith
Journal:  Anaesthesia       Date:  1972-01       Impact factor: 6.955

9.  Effect of glucocorticoids on liver and blood cholinesterases.

Authors:  Z H Verjee; R Behal; E M Ayim
Journal:  Clin Chim Acta       Date:  1977-11-15       Impact factor: 3.786

10.  Effect of glucocorticoids on plasma cholinesterase in the rat.

Authors:  V Bradamante; E Kunec-Vajić
Journal:  Biomed Biochim Acta       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.